Lipid Composition for APSG-201 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
---|---|---|---|
L-alpha-phosphatidylserine | 0.98 | 0.805 | 65 |
Cholesterol | 0.45 | 0.174 | 30 |
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt) | 0.075 | 0.210 | 5 |
Total | 1.5 µmol/vial | 1.189 mg/vial | 100 |
Lipid Composition for APSG-202 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
---|---|---|---|
L-alpha-phosphatidylserine | 0.9 | 0.743 | 60 |
L-alpha-phosphatidylcholine | 0.075 | 0.059 | 5 |
Cholesterol | 0.45 | 0.174 | 30 |
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt) | 0.075 | 0.210 | 5 |
Total | 1.5 µmol/vial | 1.186 mg/vial | 100 |
Lipid Composition for APSG-203 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
---|---|---|---|
L-alpha-phosphatidylserine | 0.75 | 0.62 | 50 |
L-alpha-phosphatidylcholine | 0.225 | 0.177 | 15 |
Cholesterol | 0.451 | 0.174 | 30 |
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt) | 0.075 | 0.210 | 5 |
Total | 1.5 µmol/vial | 1.181 mg/vial | 100 |
Lipid Composition for APSG-204 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
---|---|---|---|
L-alpha-phosphatidylserine | 0.6 | 0.495 | 40 |
L-alpha-phosphatidylcholine | 0.375 | 0.295 | 25 |
Cholesterol | 0.45 | 0.174 | 30 |
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt) | 0.075 | 0.210 | 5 |
Total | 1.5 µmol/vial | 1.174 mg/vial | 100 |
Lipid Composition for APSG-205 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
---|---|---|---|
L-alpha-phosphatidylserine | 0.451 | 0.372 | 30 |
L-alpha-phosphatidylcholine | 0.526 | 0.414 | 35 |
Cholesterol | 0.451 | 0.174 | 30 |
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt) | 0.075 | 0.210 | 5 |
Total | 1.5 µmol/vial | 1.170 mg/vial | 100 |
Lipid Composition for APSG-206 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
---|---|---|---|
L-alpha-phosphatidylserine | 0.301 | 0.248 | 20 |
L-alpha-phosphatidylcholine | 0.676 | 0.532 | 45 |
Cholesterol | 0.451 | 0.174 | 30 |
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt) | 0.075 | 0.211 | 5 |
Total | 1.5 µmol/vial | 1.165 mg/vial | 100 |
Lipid Composition for APSG-207 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
---|---|---|---|
L-alpha-phosphatidylserine | 0.15 | 0.124 | 10 |
L-alpha-phosphatidylcholine | 0.827 | 0.650 | 55 |
Cholesterol | 0.451 | 0.174 | 30 |
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt) | 0.075 | 0.211 | 5 |
Total | 1.5 µmol/vial | 1.159 mg/vial | 100 |
Lipid Composition for APSG-208 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
---|---|---|---|
L-alpha-phosphatidylserine | 0.075 | 0.0622 | 5 |
L-alpha-phosphatidylcholine | 0.90 | 0.711 | 60 |
Cholesterol | 0.45 | 0.175 | 30 |
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt) | 0.075 | 0.211 | 5 |
Total | 1.5 µmol/vial | 1.159 mg/vial | 100 |
Lipid Composition for APSG-209 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
---|---|---|---|
L-alpha-phosphatidylserine | 0.038 | 0.031 | 2.5 |
L-alpha-phosphatidylcholine | 0.94 | 0.738 | 62.5 |
Cholesterol | 0.45 | 0.174 | 30 |
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt) | 0.075 | 0.210 | 5 |
Total | 1.5 µmol/vial | 1.153 mg/vial | 100 |
Lipid Composition for APSG-210 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
---|---|---|---|
L-alpha-phosphatidylserine | 0.015 | 0.0124 | 1 |
L-alpha-phosphatidylcholine | 0.96 | 0.756 | 64 |
Cholesterol | 0.45 | 0.174 | 30 |
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt) | 0.075 | 0.211 | 5 |
Total | 1.5 µmol/vial | 1.153 mg/vial | 100 |